散发性原发性甲状旁腺功能亢进症中多腺体病如何及何时被诊断
该单中心前瞻性数据库研究纳入2013-2019年1890例散发性原发性甲状旁腺功能亢进症初次探查病例,多腺体病254例(13.4%),其中96.1%术中诊断、3.9%术后诊断。术前定位检查单独不足以发现多腺体病,至少30%病例被漏诊,术中各辅助手段均有信息价值。
要点
- 多腺体病占散发性原发性甲状旁腺功能亢进症的13.4%,96.1%在术中诊断。
- 术前SPECT/CT和超声分别提示单腺体病54.0%和49.2%,两者一致29.4%。
- 术中诊断多腺体病最常见原因为术中甲状旁腺激素监测下降不足(38.5%)。
核心结论
- 为避免原发性甲状旁腺功能亢进症甲状旁腺切除术失败,专家外科医生采用多种方法诊断和管理多腺体病。
- 术前定位检查单独不足以发现多腺体病,至少30%病例被漏诊。
- 所有 examined 辅助手段均有信息价值,包括术中甲状旁腺激素监测、影像学和术中视觉线索。
研究设计与样本
- 单中心前瞻性数据库回顾性分析,纳入2013-2019年连续1890例散发性原发性甲状旁腺功能亢进症初次探查病例。
- 术前常规行单光子发射断层扫描/计算机断层扫描和颈部超声,引导双侧或单侧探查,术中甲状旁腺激素监测采用双标准。
- 多腺体病定义为切除>1个增大甲状旁腺或单腺体切除后≥6个月出现高钙血症。
主要发现
- 1890例中多腺体病254例(13.4%),其中244例(96.1%)术中诊断、10例(3.9%)术后诊断。
- 多腺体病患者中,SPECT/CT提示单腺体病54.0%,超声提示单腺体病49.2%,两者一致提示单腺体病29.4%。
- 术中诊断多腺体病的触发因素:术中甲状旁腺激素监测下降不足38.5%,外科医生对影像解读38.1%,观察到同侧腺体增大11.0%,发现初始腺体<200 mg 10.3%,甲状腺切除术中意外发现多腺体病2.0%。
- 254例中10例(4.9%)通过术后高钙血症诊断多腺体病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In total, ∼15% of patients with sporadic primary hyperparathyroidism have multiglandular disease, which may be suspected preoperatively but can only be confirmed intra or postoperatively. The study aim is to determine how and when patients are diagnosed with multiglandular disease and to what extent different modalities contribute. METHODS: Consecutive cases of sporadic primary hyperparathyroidism (2013-2019) undergoing initial exploration were reviewed from a single-institution prospective database. Preoperative single-photon emission tomography/computed tomography and neck ultrasound were routinely performed to help direct either bilateral or unilateral exploration guided by intraoperative parathyroid hormone monitoring using the dual criteria. Multiglandular disease was defined as either resection of >1 enlarged parathyroid or hypercalcemia at ≥6 months after single gland resection. RESULTS: Of 1,890 patients with sporadic primary hyperparathyroidism, multiglandular disease was identified in 254 (13.4%); 244 (96.1%) were diagnosed intraoperatively and 10 (3.9%) postoperatively. In these multiglandular disease patients, single gland disease was suggested on single-photon emission tomography/computed tomography in 54.0%, ultrasound in 49.2%, and both were concordant for single gland disease in 29.4%. Intraoperative multiglandular disease diagnosis was prompted by an inadequate intraoperative parathyroid hormone monitoring drop in 38.5%, by surgeon interpretation of imaging in 38.1%, by observing ipsilateral gland enlargement in 11.0%, by finding an initial gland <200 mg in 10.3%, and 2.0% had unexpected multiglandular disease during thyroidectomy. Multiglandular disease was diagnosed by postoperative hypercalcemia in 10 of 254 patients (4.9%). CONCLUSION: To avoid failure at parathyroidectomy for primary hyperparathyroidism, expert surgeons use multiple approaches to diagnose and manage multiglandular disease. Preoperative localization studies alone are insufficient, missing multiglandular disease in at least 30% of cases. All examined adjuncts are informative, including intraoperative parathyroid hormone monitoring, imaging, and intraoperative visual cues.
引用
- Shah US, McCoy KL, Kelley ML, et al. How and when is multiglandular disease diagnosed in sporadic primary hyperparathyroidism? Surgery. 2022. PMID: 34924180. doi:10.1016/j.surg.2021.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。